Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/07/2010US20100255076 Composition and method for dermal regeneration
10/07/2010US20100255075 CR-2 Binding Peptide P28 as Molecular Adjuvant for DNA Vaccines
10/07/2010US20100255074 Transmembrane prostatic acid phosphatase
10/07/2010US20100255072 Dermal delivery device with in situ seal
10/07/2010US20100255069 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of angelica sinensis, and methods of preparation thereof
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255053 Medical implant with bioactive material and method of making the medical implant
10/07/2010US20100255042 Process for Producing Particles Loaded with Growth Factors as Well as the Particles Thus Obtained
10/07/2010US20100255031 truncated l1 protein of human papillomavirus type 16
10/07/2010US20100255020 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducers, and pharmaceutical compositions and vaccines employing them
10/07/2010US20100255017 Purified hemocyanin obtained from fissurella latimarginata, fissurella cumingi or fissurella maxima; subunit of purified hemocyanin; use of hemocyanin, its subunit or immunogenic fragments and compositions containing the same
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255011 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100255004 Receptor tyrosine kinase profiling
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100255000 Antidotes for factor xa inhibitors and methods of using the same
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254996 Synergistic treatment of cells that express epha2 and erbb2
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254984 Fusion constructs containing active sections of tnf ligands
10/07/2010US20100254983 Uses of rage antagonists for treating obesity and related diseases
10/07/2010US20100254982 Cancer specific antibody and cell surface proteins
10/07/2010US20100254970 Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
10/07/2010US20100254968 Pharmaceutical preparation for treating benign prostatic hyperplasia
10/07/2010US20100254966 Treatment of glycogen storage disease type ii
10/07/2010US20100254965 Adenosine Signaling in Diagnosis, Treatment, and Prevention of Priapism and Erectile Dysfunction
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010US20100254963 Peg-modified arginine/lysine oxidoreductase
10/07/2010US20100254961 Water-soluble electrospun sheet
10/07/2010US20100254949 Prebiotic oligosaccharides
10/07/2010US20100254947 SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF
10/07/2010US20100254946 Maintenance of hair growth and treatment of hair-loss
10/07/2010US20100254944 Albumin Fusion Proteins
10/07/2010US20100254943 Amino acid substituted molecules
10/07/2010US20100254942 Hepatitis c antiviral compositions and methods
10/07/2010US20100254941 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
10/07/2010US20100254940 Compositions and Methods for Regulating an Immune Response in a Subject
10/07/2010US20100254939 Graft copolymers as drug delivery systems
10/07/2010US20100254938 Formulation having mobilising activity
10/07/2010US20100254937 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
10/07/2010US20100254916 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
10/07/2010US20100254914 Nanoworms for in vivo tumor targeting
10/07/2010US20100254901 Compositions comprising nucleic acid aptamers
10/07/2010US20100254900 Biocompatible polymers and Methods of use
10/07/2010DE102005028271B4 Proteingemisch enthaltend VSV-G zur Verstärkung der Immunantwort Mixture comprising VSV-G protein to enhance the immune response
10/07/2010CA2794577A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
10/07/2010CA2773686A1 Process for making a milk-based protein hydrolysate
10/07/2010CA2760564A1 Protein-assisted drug delivery system for the targeted administration of active agents for overcoming blood-brain barrier
10/07/2010CA2759201A1 A method of regulating proliferation and differentiation of keratinocyes
10/07/2010CA2757524A1 Methods for preparing and using multichaperone-antigen complexes
10/07/2010CA2757500A1 Pulmonary and nasal delivery of serum amyloid p
10/07/2010CA2757449A1 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
10/07/2010CA2757240A1 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
10/07/2010CA2757095A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010CA2757076A1 Compositions and methods for treatment of aortic fibrosis
10/07/2010CA2756959A1 Pro-apoptotic peptides
10/07/2010CA2756864A1 Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase)-inhibitory peptide, and use of the peptide
10/07/2010CA2755878A1 Inhibition of biofilm organisms
10/07/2010CA2755860A1 Improvement in promotion of healthy catch-up growth
10/07/2010CA2754395A1 A peg-albumin composition having at least one protected thiol region as a platform for medications
10/07/2010CA2750701A1 Method for production of lactoferrin
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2237040A2 Determination of level of immunoglobulin fragmentation or modification and use of a trypsin inhibitor for preventing the same
10/06/2010EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
10/06/2010EP2236620A2 Compositions and methods for detecting and treating HIV infection
10/06/2010EP2236609A2 DNA-based aptamers for human cathepsin G
10/06/2010EP2236608A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
10/06/2010EP2236603A1 Pro-apoptotic peptides
10/06/2010EP2236516A1 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury
10/06/2010EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
10/06/2010EP2236507A1 N-pyrazole-2-pyridinecarboxamide derivative
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236153A2 Compositons and methods for treating cardiac conditions
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236151A1 Melanocortin receptor ligands
10/06/2010EP2236133A1 Pharmaceutical composition comprising fentanyl for the treatment of acute or breakthrough pain by sublingual administration
10/06/2010EP2236132A1 Pharmaceutical composition for the treatment of insomnia by sublingual administration
10/06/2010EP2235189A1 Methods for inhibiting angiogenesis using egfl8 antagonists
10/06/2010EP2235178A2 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
10/06/2010EP2235064A1 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
10/06/2010EP2235046A2 Mutant forms of streptolysin o
10/06/2010EP2235044A1 New polypeptides having affinity for her2
10/06/2010EP2235042A1 New blood coagulation factor inhibitors
10/06/2010EP2235041A2 Antimicrobial compounds
10/06/2010EP2234645A2 Peg-interferon-beta formulations
10/06/2010EP2234644A1 Insulin formulations for insulin release as a function of tissue glucose levels
10/06/2010EP2234635A2 Rhoc-based immunotherapy
10/06/2010EP2234633A1 A method of treating neurodegenerative diseases
10/06/2010EP2234632A2 Proteinaceous compounds
10/06/2010EP2234631A1 Compounds and methods for the treatment of vascular disease
10/06/2010EP2234629A1 Stable aqueous cyclosporin compositions
10/06/2010EP2234628A2 Compositions and methods of promoting wound healing
10/06/2010EP2234603A1 Room temperature stable, lyophilized natriuretic peptide formulations
10/06/2010EP2234598A1 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
10/06/2010EP2137539B1 Amiloride sensitive sodium channels associated with panic disorders
10/06/2010EP1885744B1 Substrate for rpn 11 enzymatic activity
10/06/2010EP1706133B1 Methods of protecting against radiation using flagellin
1 ... 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 ... 3163